Androgenetic alopecia

Researchers are testing an experimental topical gel called PP405 in men with androgenetic alopecia, the most common form of male pattern hair loss. The trial enrolls about 600 men aged 18 to 55 with moderate hair loss at the top of the scalp. Participants apply either the PP405 g…

This trial tests two food supplements for hair health in men aged 35 to 65 with mild to moderate male pattern baldness. Participants take one capsule daily for 84 days, and researchers compare the supplements against a placebo. The study measures changes in hair density, hair los…

This Phase 3 trial tests a new topical drug called APSMNF for male pattern baldness. About 336 men aged 18 to 60 will apply it twice daily for 24 weeks. Researchers will measure changes in hair density using a special camera and track any side effects.

This pilot study will test whether a daily gummy supplement called Xtressé can safely improve hair growth in 40 men with male pattern baldness. Participants take two gummies each day for six months, and researchers measure changes in hair density and thickness using special camer…

This study tests whether an injection called XVIE, made from processed human amniotic fluid, is safe and might help regrow hair in adults with common pattern baldness. Thirty participants will receive either XVIE or a placebo injected into the scalp, with two treatments 90 days a…

This trial investigates whether combining microneedling with a standard 5% minoxidil solution can improve hair regrowth in men with androgenetic alopecia (male pattern baldness). It will enroll 190 men aged 18-55 with specific hair loss grades, who will receive different micronee…

This trial compares three types of platelet-rich plasma (PRP) injections for androgenetic alopecia, the most common form of hair loss. Participants receive either standard PRP, PRP enhanced with red light, or PRP enhanced with blue light, and are blinded to which type they get. T…

This study tests whether a daily oral minoxidil pill (N1087) can help regrow hair in men with male pattern baldness. About 372 men aged 18 to 60 with moderate hair loss will take either the drug or a placebo for 24 weeks, with the dose slowly increased. The main goal is to see if…

This study tests whether a treatment called DA-001 can safely reduce hair shedding and promote regrowth in people with certain types of hair loss, including telogen effluvium and female or male pattern baldness. About 1,120 adults will apply the treatment as directed and be monit…

This study tests whether a single injection of nanofat (processed fat from your own body) can treat pattern hair loss better than standard options. Sixty adults with androgenetic alopecia will receive either one nanofat injection, three monthly PRP injections, or daily topical mi…

This early-stage study tests two forms of a hair loss drug (AD-303A topical and AD-3031 oral) in 30 men aged 19-55 with male pattern baldness. The goal is to see how the drug moves through the body, how well it works, and if it is safe. The study will help decide the right dose f…

This Phase 3 trial tests whether an oral solution called N1087 can help women with female pattern hair loss regrow hair. About 372 women aged 18 to 60 will receive either N1087 or a placebo daily for 24 weeks. The study measures changes in hair density and thickness using scalp p…

This study tests whether adding platelet-rich plasma (PRP) or nanofat injections to standard hair transplants helps more hair grafts survive and grow thicker. Thirty men with stable male pattern baldness will receive both treatments on different scalp areas, and doctors will meas…

This study compares two forms of minoxidil—a topical spray and an oral pill—for treating androgenetic alopecia (common hair loss) in 200 men and women aged 18 to 50. Over 6 months, researchers will measure hair regrowth, shedding, and side effects. Participants will use either th…

This study tests whether adding a stem-cell-derived exosome solution to fractional laser therapy helps regrow hair better than laser alone. Thirty men with male pattern baldness will receive three laser sessions and be followed for six months. Researchers will measure changes in …

This study aims to train and test artificial intelligence (AI) models to diagnose male and female pattern hair loss (androgenetic alopecia) and assess its severity. Researchers will use images from a handheld dermoscope along with age and sex data from 400 participants. The goal …

This early-stage study tests whether platelet-rich plasma (PRP) therapy, made from a participant's own blood, can help women with androgenic alopecia (female pattern hair loss). Sixteen women will receive PRP injections, and researchers will measure changes in hair loss severity …

Researchers at Al-Azhar University are studying whether type 2 diabetes is linked to changes in women's hair and scalp. The study compares 130 women aged 20 to 60, half with diabetes for at least a year and half healthy controls matched by age. Participants undergo clinical hair …

This study investigates whether the bacteria living in the gut and on the scalp differ between men with androgenetic alopecia (common hair loss) and those without. Researchers will also look at how these bacterial communities change after treatment with oral minoxidil, a standard…